Successful treatment of chronic pain:

Study

Successful treatment of chronic pain: clinical-prospective, double-blind-randomised and placebo-controlled Study

In recent years, Rayonex Biomedical has conducted various studies on bioresonance according to Paul Schmidt. Probably the most significant is the new clinical-prospective, double-blind randomised & placebo-controlled study on pain reduction in patients with cervical spine syndrome. It proves that bioresonance according to Paul Schmidt literally works with waves of success.

In the case of neck pain, headaches, back pain and tension, no significant improvement was achieved under placebo treatment. When treated with the Rayocomp bioresonance device, all parameters showed significant improvements.

With this scientific study there is now proof for patient and therapist of a safe and effective application of bioresonance according to Paul Schmidt. The result of the study thus proves what our users have already been confirming to us for decades: Bioresonance therapy according to Paul Schmidt alleviates complaints and helps patients to achieve a new sense of health and well-being.

SCIENTIFICALLY PROVEN EFFICACY

Significant Improvements

"The Rayocomp PS 1000 polar 4.0 bioresonance device achieved significant improvements in all objective and subjective parameters of the study when compared to the placebo device."

FROM THE Summary (7 Discussion and Conclusions) of the FINAL CLINICAL REPORT BY DR. HANS WERNER VOSS, PUBLISHED IN THE BOOK "SUCCESSFUL TREATMENT OF CHRONIC PAIN"  BY RAYONEX BIOMEDICAL GMBH FROM THE YEAR 2020.

Study participants

0
Patients (27 - 84 years old)
0
Female Patients
0
Male Patients
0
Groups (Placebo & Rayocomp)

High recommendation rates

„Overall, there were significant differences in how patients answered the question of whether they would recommend the treatment to others. All patients in the Rayocomp group said that they would recommend it, while only around a quarter of patients in the placebo group said the same.“

ASSESSMENT OF THE THERAPY

CONTROL GROUP (PLACEBO)

EXPERIMENTAL GROUP (RAYOCOMP)

Number (n) Proportion % Number (n) Proportion %
Therapy recommendation 6 26,1% 24 100,0%
No recommendation of the therapy 17 73,9% 0 0,0%

FROM THE FINAL CLINICAL REPORT BY DR. HANS WERNER VOSS, PUBLISHED IN THE BOOK “SUCCESSFUL TREATMENT OF CHRONIC PAIN” BY RAYONEX BIOMEDICAL GMBH FROM THE YEAR 2020.

Our medical devices

Medical application of bioresonance according to Paul Schmidt with approved class I and class IIa medical products for clinics, medical practitioners, alternative practitioners, therapists and, of course, home use.

Rayocomp PS 1000 polar 4.0 med.

Development costs of approx. 3.5 million euros were invested in the development and approval in order to meet the current medical product standards. The evolution within bioresonance according to Paul Schmidt - Made in Germany.

Rayocomp PS 10 med.

Despite its small dimensions, our Rayocomp PS 10 med. has it all - this is an excellent and robust companion not only for mobile use - of course "Made in Germany".

Further studies & scientific papers

Would you like to learn more?

Please note that the given information, advices and solution approaches are originated from more than 40 years of experience. But they can not replace the consultation of a medical practitioner or a naturopathy orientated doctor.

Scroll to Top